A Late-stage Trial of Biogen's Experimental Treatment for an Inherited Form of ALS, Also ... - Latest Tweet by Reuters

A late-stage trial of Biogen's experimental treatment for an inherited form of ALS, also known as Lou Gehrig’s disease, failed to reach its main goal, but secondary measures and biomarkers showed favorable trends, the company said https://t.co/aAJuKeIA7V pic.twitter.com/W92OQqRTQm— Reuters (@Reuters) October 17, 2021

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)